Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion type Assertion NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_head.
- NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion description "[In parallel, data obtained in a primary breast cancer clinical series showed that disease-free survival was shorter in individuals bearing the CCR5Delta32 allele than in CCR5 wild-type patients, but only for those whose tumors expressed wild-type p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_provenance.
- NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion evidence source_evidence_literature NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_provenance.
- NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion SIO_000772 14597737 NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_provenance.
- NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion wasDerivedFrom befree-20140225 NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_provenance.
- NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_assertion wasGeneratedBy ECO_0000203 NP655478.RAIn6hYDnnnTGJUSZ0uYPGkzE6j-lbiiSZmCic20sM_FI130_provenance.